Novartis, Roche back French gene therapy start-up Vivet – Reuters
Endpoints News |
Novartis, Roche back French gene therapy start-up Vivet
Reuters Gene therapy seeks to cure rare genetic diseases by offering a one-time fix of a faulty DNA. There is rising interest in the field, even though the Western world’s first gene therapy for an ultra-rare condition is being pulled from the market due to … French Gene Therapy Biotech Raises a Huge €37.5M in Series ALabiotech.eu (blog) GenSight vet Combal grabs $40M from Novartis, Roche group for second-wave gene therapy biotechEndpoints News Vivet Therapeutics Raises €37.5 Million in Series A Financing Round to Advance Novel Gene Therapies for Treating …PR Newswire (press release) |
Endpoints News |
Novartis, Roche back French gene therapy start-up Vivet
Reuters Gene therapy seeks to cure rare genetic diseases by offering a one-time fix of a faulty DNA. There is rising interest in the field, even though the Western world’s first gene therapy for an ultra-rare condition is being pulled from the market due to … French Gene Therapy Biotech Raises a Huge €37.5M in Series ALabiotech.eu (blog) GenSight vet Combal grabs $40M from Novartis, Roche group for second-wave gene therapy biotechEndpoints News |
|
New study uses 10x Genomics’ Single Cell 3′ Solution to unravel stem cell self-renewal mechanism
News-Medical.net This carefully regulated process occurs within a stem–cell niche called the intestinal crypt, and depends on Wnt signaling, which can be turned up by Wnt and R-spondin (RSPO) ligands. The authors sought to identify the unique functional roles of Wnt … |
|
GenSight vet Combal grabs $40M from Novartis, Roche group for second-wave gene therapy biotech
Endpoints News Up until some months ago, Jean-Philippe Combal had been the COO at Paris-based GenSight Biologics, focused on a closely-watched late-stage study of an experimental gene therapy for Leber’s Hereditary Optic Neuropathy (or LHON), a rare mitochondrial … |
Medical Xpress |
Testing a new immunotherapy treatment for neuroblastoma
Medical Xpress It’s an early stage clinical trial that we’re running at Great Ormond Street Hospital and University College Hospital, testing the potential of a new type of immunotherapy to treat neuroblastoma – an aggressive type of cancer that most commonly occurs … |
TechCrunch |
Scientists have eliminated HIV in mice using CRISPR
TechCrunch An important breakthrough has been made in the eradication of AIDs. Scientists have found they can successfully snip out the HIV virus from mouse cells using CRISPR/Cas9 technology. Right now patients with the deadly virus must use a toxic concoction … CRISPR and the Dawn of the New Biotech RevolutionReason (blog) Researchers use gene editing to eliminate HIV infection in miceCBS News CRISPR Eliminates HIV in Live AnimalsGenetic Engineering & Biotechnology News Technology Networks –CNET –ScienceDirect –Temple Health all 52 news articles » |
The San Diego Union-Tribune |
California’s stem cell agency loses transformational leader
The San Diego Union-Tribune C. Randal Mills, president and CEO of the California Institute for Regenerative Medicine, briefly recaps progress the state agency has made since 2014 in getting stem cell therapies into clinical trials. Taken on July 21, 2016, at the Sanford … |